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Proceedings ofthe Fourth International Workshop on Multiple Endocrine Neoplasia

Introduction
Science is the most communal of human endeavors
Lewis Thomas
(Foreign Affairs 1984;63:966-94)

he Fourth Intemational Workshop on Multiple Endocrine
Neoplasia (MEN) was held at the Methodist Hospital,
Houston, TX, October 3-5, 1991. This workshop was patterned
on previous workshops held in Kingston, Ontario (1), Cambridge, England (2), and Heidelberg, Germany (3). Prior workshops focused exclusively on the MEN 2 syndrome. The Houston workshop brought together, for the first time, investigators
and clinicians studying both MEN 1 and MEN 2 to compare and
contrast investigative findings in these two interesting and important genetic cancer syndromes. That this was an intemational
gathering was evidenced by the fact that investigators from five
continents were present at this meeting, each presenting a
unique view of these syndromes.
A key focus of this meeting was the fostering of discussion
and the development of collaborative efforts to localize further
the primary genetic abnormalities for the.se two syndromes and
to understand subsequent cellular events leading to disordered
cellular growth. Although neither gene had been identified at the
time of the Houston workshop, there was evidence of sustained
progress toward localization which included more detailed
mapping of the loci for MENl and MEN2 and identification of
genomic clones from the disease gene regions. Several genes in
these regions have been cloned and largely excluded as candidate genes, the first step in the process toward the identification
of the disease genes.
As a gesture of welcome to the investigators working on
MEN 1, it seems appropriate to begin this issue of the Workshop
Proceedings with an article by Larsson et al who describe progress toward identification of the MEN 1 gene. Other manuscripts from the major groups working on MEN 1 describe advances toward the localization of the gene, variant syndromes,
tumor biology, and experience with clinical management ofthis
syndrome.
The second portion of this issue focuses on consolidation of
information regarding the MEN 2 locus. Several groups are now
screening libraries containing large segments of DNA from
the chromosome 10 centromeric region. One candidate gene
thought to be involved in regulation of the cell cycle has been
examined and tentatively rejected as a candidate gene. Of particular significance to clinicians were the discussions of reoperation in the management of metastatic medullary thyroid carcinoma and the development of recommendations for the use of
genetic screening information. There was a further expansion of

T

158

Henry Ford Hosp Med J—Vol 40, Nos 3 & 4,1992

information presented about MEN 2A/cutaneous lichen amyloidosis syndrome, a variant syndrome initially thought to be
rare but now identified in at least eight families in diverse geographic locations. Although abstracts of some of the additional
material presented are published here (pp. 312-318), other important papers and formal and informal discussions are not covered.
In keeping with the friendly and cooperative spirit of these
meetings, an ad hoc committee of MEN 2 investigators was
formed to develop technical guidelines for use of DNA probes
for genetic screening and to develop a mechanism by which new
probes can be shared with interested investigators.
The organizers of the Fourth MEN Workshop are particularly
thankful to the Methodist Hospital and the Methodist Hospital
Foundation for their financial support and for the beautiful facilities made available for this gathering.*
In addition, financial contributions for support of the Workshop were received from the Dykstra Foundation, Detroit, MI,
and the Bin Mahfouz family of Saudi Arabia. We would also
like to thank Sandoz Pharmaceuticals Corporation, Norwich
Eaton Pharmaceuticals, CIBA-GEIGY Corporation, the Upjohn
Company, Merck Sharp & Dohme, Nichols Institute, and Blackwell Scientific Publications for educational grants to support the
Workshop.
Finally, we look forward to the Fifth Intemational Workshop
on Multiple Endocrine Neoplasiaf to be held in the summer of
1994 in Stockholm, Sweden.
Robert F. Gagel, MDt
Charles E. Jackson, MD§
Guest Coeditors
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*The p.TTticipants were al.so appreciative of the organization of the workshop and impressed with the warm Te.xas hospitality of Dr. Gagel's committee (CEI).
tFor further information on the Fifth International Workshop on Multiple Endocrine
Neoplasia, contact Magnus Nordenskjold, MD, Depai-tment of Clinical Genetics, Karolinska Hospital, PO Box 60500, S-l04 01, Stockholm, Sweden.
^Section of Endocrinology, M.D. Anderson Cancer Center, Houston, TX.
JjDepailment of Intemal Medicine, Division of Clinical and Molecular Genetics, Henry
Ford Hospital.
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